{"id":869482,"date":"2025-07-14T18:58:23","date_gmt":"2025-07-14T22:58:23","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\/"},"modified":"2025-07-14T18:58:23","modified_gmt":"2025-07-14T22:58:23","slug":"hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\/","title":{"rendered":"$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sonnet BioTherapeutics, Inc. (NASDAQ: SONN)"},"content":{"rendered":"
\n

NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) — <\/p>\n

\n Class Action Attorney <\/strong>
\n
\n Juan Monteverde<\/u>
\n <\/a>
\n with <\/strong>
\n
\n Monteverde & Associates PC<\/u>
\n <\/a> (the \u201cM&A Class Action Firm\u201d), has recovered millions of dollars for shareholders and is recognized as a Top 50\u00a0Firm <\/strong>in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the\u00a0Empire State Building<\/strong>\u00a0in New York City and is investigating Sonnet BioTherapeutics, Inc. (NASDAQ: <\/strong>SONN<\/strong><\/a>) <\/strong>related to its merger with Rorschach I LLC. Upon completion of the proposed transaction, Sonnet shareholders will own approximately 1% of the combined company. Is it a fair deal?<\/u><\/strong><\/p>\n

\n Click here for more info <\/strong>
\n
\n https:\/\/monteverdelaw.com\/case\/sonnet-biotherapeutics-inc\/<\/strong>
\n <\/a>
\n .<\/strong>
\n It is free and there is no cost or obligation to you.<\/strong>\n <\/p>\n

\n NOT ALL LAW FIRMS ARE EQUAL. <\/strong>Before you hire a law firm, you should talk to a lawyer and ask:<\/p>\n

    \n
  1. Do you file class actions and go to Court?<\/li>\n
  2. When was the last time you recovered money for shareholders?<\/li>\n
  3. What cases did you recover money in and how much?\n<\/li>\n<\/ol>\n

    \n About Monteverde & Associates PC<\/strong>\n <\/p>\n

    Our firm litigates and has recovered money for shareholders\u2026and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S.\u00a0Supreme Court.\u00a0<\/p>\n

    \n No one is above the law.<\/strong> If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website<\/u><\/strong><\/a> or contact Juan Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com<\/u><\/strong><\/a> or by telephone at (212) 971-1341.<\/p>\n

    Contact:
    Juan Monteverde, Esq.
    MONTEVERDE & ASSOCIATES PC
    The Empire State Building<\/strong>
    350 Fifth Ave. Suite 4740
    New York, NY 10118
    United States of America
    jmonteverde@monteverdelaw.com<\/u><\/a>
    Tel: (212) 971-1341<\/p>\n

    Attorney Advertising. (C) 2025 Monteverde & Associates PC.\u00a0The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com<\/u><\/a>).\u00a0 Prior results do not guarantee a similar outcome with respect to any future matter.<\/p>\n

    \"\"
    \n
    \n \"\"\n <\/div>\n

    <\/div>\n","protected":false},"excerpt":{"rendered":"

    NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) — Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the \u201cM&A Class Action Firm\u201d), has recovered millions of dollars for shareholders and is recognized as a Top 50\u00a0Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the\u00a0Empire State Building\u00a0in New York City and is investigating Sonnet BioTherapeutics, Inc. (NASDAQ: SONN) related to its merger with Rorschach I LLC. Upon completion of the proposed transaction, Sonnet shareholders will own approximately 1% of the combined company. Is it a fair deal? Click here for more info https:\/\/monteverdelaw.com\/case\/sonnet-biotherapeutics-inc\/ . It is free and there is no cost or obligation to you. NOT ALL LAW FIRMS ARE EQUAL. Before … <\/p>\n

    Continue reading “$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sonnet BioTherapeutics, Inc. (NASDAQ: SONN)”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-869482","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\n$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sonnet BioTherapeutics, Inc. (NASDAQ: SONN) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sonnet BioTherapeutics, Inc. (NASDAQ: SONN) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) — Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the \u201cM&A Class Action Firm\u201d), has recovered millions of dollars for shareholders and is recognized as a Top 50\u00a0Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the\u00a0Empire State Building\u00a0in New York City and is investigating Sonnet BioTherapeutics, Inc. (NASDAQ: SONN) related to its merger with Rorschach I LLC. Upon completion of the proposed transaction, Sonnet shareholders will own approximately 1% of the combined company. Is it a fair deal? Click here for more info https:\/\/monteverdelaw.com\/case\/sonnet-biotherapeutics-inc\/ . It is free and there is no cost or obligation to you. NOT ALL LAW FIRMS ARE EQUAL. Before … Continue reading "$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sonnet BioTherapeutics, Inc. (NASDAQ: SONN)"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-14T22:58:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ5NDM4OCM3MDQ3NzY5IzIxODQzNTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sonnet BioTherapeutics, Inc. (NASDAQ: SONN)\",\"datePublished\":\"2025-07-14T22:58:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\\\/\"},\"wordCount\":345,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ5NDM4OCM3MDQ3NzY5IzIxODQzNTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\\\/\",\"name\":\"$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sonnet BioTherapeutics, Inc. (NASDAQ: SONN) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ5NDM4OCM3MDQ3NzY5IzIxODQzNTk=\",\"datePublished\":\"2025-07-14T22:58:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ5NDM4OCM3MDQ3NzY5IzIxODQzNTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ5NDM4OCM3MDQ3NzY5IzIxODQzNTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sonnet BioTherapeutics, Inc. (NASDAQ: SONN)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sonnet BioTherapeutics, Inc. (NASDAQ: SONN) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\/","og_locale":"en_US","og_type":"article","og_title":"$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sonnet BioTherapeutics, Inc. (NASDAQ: SONN) - Market Newsdesk","og_description":"NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) — Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the \u201cM&A Class Action Firm\u201d), has recovered millions of dollars for shareholders and is recognized as a Top 50\u00a0Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the\u00a0Empire State Building\u00a0in New York City and is investigating Sonnet BioTherapeutics, Inc. (NASDAQ: SONN) related to its merger with Rorschach I LLC. Upon completion of the proposed transaction, Sonnet shareholders will own approximately 1% of the combined company. Is it a fair deal? Click here for more info https:\/\/monteverdelaw.com\/case\/sonnet-biotherapeutics-inc\/ . It is free and there is no cost or obligation to you. NOT ALL LAW FIRMS ARE EQUAL. Before … Continue reading \"$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sonnet BioTherapeutics, Inc. (NASDAQ: SONN)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\/","og_site_name":"Market Newsdesk","article_published_time":"2025-07-14T22:58:23+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ5NDM4OCM3MDQ3NzY5IzIxODQzNTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sonnet BioTherapeutics, Inc. (NASDAQ: SONN)","datePublished":"2025-07-14T22:58:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\/"},"wordCount":345,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ5NDM4OCM3MDQ3NzY5IzIxODQzNTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\/","name":"$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sonnet BioTherapeutics, Inc. (NASDAQ: SONN) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ5NDM4OCM3MDQ3NzY5IzIxODQzNTk=","datePublished":"2025-07-14T22:58:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ5NDM4OCM3MDQ3NzY5IzIxODQzNTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ5NDM4OCM3MDQ3NzY5IzIxODQzNTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-sonnet-biotherapeutics-inc-nasdaq-sonn\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sonnet BioTherapeutics, Inc. (NASDAQ: SONN)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/869482","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=869482"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/869482\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=869482"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=869482"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=869482"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}